Search
for
Sort by
Research 61–90 of 1000+
- Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- THERAPEUTIC ASPECTS OF ONION IN TREATMENT OF CANCER AND RELATED ISSUES: A REVIEW
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- Hair loss during and after breast cancer therapy
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Exploring the therapeutic potential of Selaginella doederleinii extract for cervical cancer treatment through network pharmacology and in vitro studies
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waiting
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Decellularized tumor matrices as biomimetic cancer niche: a new perspective on cancer research and therapy
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Management of the adverse effects of targeted therapy for cancer
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Radioprotective Effects of Soy Isoflavones on Normal Lung Tissue Could Translate to Improve Radiation Therapy Outcome of Lung Cancer
- RANK as a therapeutic target in cancer
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Potential of nano-phytochemicals in cervical cancer therapy
- Androgen receptor: A promising therapeutic target in breast cancer
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Advancing Design Strategy of PROTACs for Cancer Therapy
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B
- FERTILITY-SPARING MANAGEMENT OF ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA & ENDOMETRIAL CANCER: A COMPARISON OF THE LEVONORGESTREL-RELEASING INTRAUTERINE DEVICE VS SYSTEMIC THERAPY